24
Growth Score
pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Maas Biolab is a small neuropharmaceutical company
About the Company
Maas Biolab is a small neuropharmaceutical company developing a treatment for amyotrophic lateral sclerosis – using cyclosporin as a neuro-protectant drug. Maas Biolab’s patent and related intellectual property rights consist formulation patents and production patents for cyclosporins as neuroprotective agents. More importantly, Maas Biolab has FDA
Orphan Drug Designation for cyclosporin to treat ALS.
